Aphakia Market Report 2026

Aphakia Market Overview

• Aphakia market size has reached to $1.89 billion in 2025 • Expected to grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Rising Cataract Prevalence Fuels Growth In The Aphakia Market • Market Trend: Advancements In Aphakia Market Alcon's Clareon Vivity IOL Enhances Vision With EDOF Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Aphakia Market?

Aphakia is the absence of the crystalline lens in the eye, which can lead to significant visual impairment because the lens is crucial for focusing light onto the retina. This can occur due to surgical removal of the lens (cataract surgery), trauma, or other conditions that lead to the loss of the natural lens. The main types in the aphakia market are congenital aphakia, surgical aphakia, and acquired aphakia. Congenital aphakia refers to a condition present at birth where an individual is born without a natural lens in one or both eyes. The various treatments include spectacles, contact lenses, intraocular lens implantation, and refractive surgery, and end user involve are hospitals, ophthalmic clinics, and others.

What Is The Aphakia Market Growth Forecast?

The aphakia market size is expected to see rapid growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing innovation in intraocular lens technologies, rising adoption of minimally invasive eye surgeries, expansion of personalized vision correction solutions, growing focus on pediatric ophthalmic care, increasing investments in advanced eye care infrastructure. Major trends in the forecast period include increasing adoption of intraocular lens implantation, rising demand for advanced refractive surgery options, growing use of customized contact lens solutions, expansion of pediatric aphakia management approaches, enhanced focus on post-surgical visual rehabilitation.

What Is The Driver Of The Aphakia Market?

The rising prevalence of cataracts is expected to propel the growth of the aphakia market going forward. Cataracts refer to a condition where the eye's lens becomes cloudy, leading to impaired vision. Cataract cases are growing populations, higher incidences of diabetes, excessive exposure to sunlight, smoking, and poor nutrition. Cataract causes aphakia by necessitating the removal of the natural lens of the eye during surgery to treat the clouded lens, leaving the eye without its natural lens. For instance, in May 2024, according to the Office for Health Improvement and Disparities, a UK-based government body, in England, cataract surgery admissions among individuals aged 65 and over increased from 516,073 in the financial year ending 2023 to 581,369 in the financial year ending 2024, reflecting a notable rise in demand for surgical intervention. Therefore, the rising prevalence of cataracts is driving the aphakia industry.

Key Players In The Global Aphakia Market

Major companies operating in the aphakia market are Johnson & Johnson Services Inc., Alcon Laboratories Inc., Hoya Corporation, CooperVision Inc., Carl Zeiss AG, Santen Pharmaceutical Co. Ltd., Appasamy Associates, Aurolab, Rayner Intraocular Lenses Limited, Ophtec BV, SIFI SpA, Aaren Scientific Inc., Mediphacos, Hanita Lenses Ltd., Menicon Co. Ltd., Lenstec Inc., Morcher GmbH, Bausch & Lomb Incorporated, Nidek Co. Ltd., Swiss Advanced Vision AG, UltraVision CLPL, Medennium Inc.

Global Aphakia Market Trends and Insights

Major companies operating in the aphakia market are developing presbyopia-correcting intraocular lenses (IOLs) to enhance visual outcomes and patient satisfaction. Presbyopia-correcting IOLs help in aphakia by restoring vision and correcting presbyopia, allowing clear sight at multiple distances without extra eyewear. For instance, in November 2023, Alcon, a Switzerland-based surgical equipment company, launched Clareon Vivity in Canada. It is an innovative nondiffractive extended depth of focus (EDOF) intraocular lens (IOL), offering high-quality vision with minimal visual disturbances. The Clareon Vivity IOL is used to treat aphakia, which is a condition where the eye's natural lens has been removed, typically during cataract surgery. Utilizing x-wave technology enhances focus without splitting the wavefront, reducing halos for a more precise visual experience. This innovation marks a significant advancement in the aphakia market, providing cataract patients with a superior option for presbyopia correction.

What Are Latest Mergers And Acquisitions In The Aphakia Market?

In July 2024, iCare Health Solutions, a US-based ocular care services company, acquired Beraja Medical Group for an undisclosed amount. Through this acquisition, iCare Health Solutions aims to expand its eyecare services and improve patient outcomes. This move is to increase access to high-quality care and integrate established expertise into iCare’s network. It also ensures continued local operations and familiar staff for the community. Beraja Medical Group is a US-based company specializing in comprehensive ophthalmology with expertise in advanced eye care and aesthetic services, including aphakia.

What Defines the Aphakia Market?

The aphakia market consists of revenues earned by entities by providing services such as diagnosis, surgical implantation of intraocular lenses (IOLs), postoperative care, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The aphakia market also includes sales of intraocular lenses (IOLs), contact lenses, spectacles, and ocular implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aphakia Market Report 2026?

The aphakia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aphakia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.